GSK – Discover Pharma

Welcome to Discover Pharma! Today is : March 11, 2026

GSK

Chronic diseases,Drug approval,Drug Delivery & Formulation,Immunology,Pharmaceuticals and therapeutics,Respiratory
Exdensur approved by European Commission for severe asthma and chronic rhinosinusitis with nasal polyps
GSK announced that the European Commission has approved Exdensur (depemokimab) [...]

February 18, 2026
CDMOs & Manufacturing,Market Access & Commercialization,Sustainability
Net-zero in action: ABB powers GSK’s sustainability leap in Singapore
GlaxoSmithKline Biologicals (GSK) has advanced its net-zero ambitions at its [...]

November 25, 2025
Chronic diseases,Drug Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development
Ochre Bio and GSK complete research phase with large-scale human liver genomics datasets
Ochre Bio has completed the research phase of its collaboration [...]

November 18, 2025
Clinical Trials,Drug approval,Pharmaceuticals and therapeutics,Respiratory
GSK’s depemokimab backed by Phase 3 data ahead of FDA decision in asthma and sinusitis
Phase 3 data for GSK’s depemokimab appear to support the [...]

October 8, 2025
Artificial Intelligence,Drug Development,Movers & Shakers
Ochre Bio appoints pharma veteran Elaine Sullivan as senior independent director
RNA therapeutics developer Ochre Bio has appointed Dr Elaine Sullivan [...]

May 29, 2025

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK